CoChat

Time course of lung retention and toxicity of inhaled particles: short-term exposure to nano-Ceria

Open access

The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.

Abstract

Two Ceria nanomaterials (NM-211 and NM-212) were tested for inhalation toxicity and organ burdens in order to design a chronic and carcinogenicity inhalation study (OECD TG No. 453). Rats inhaled aerosol concentrations of 0.5, 5, and 25 mg/m 3 by whole-body exposure for 6 h/day on 5 consecutive days for 1 or 4 weeks with a post-exposure period of 24 or 129 days, respectively. Lungs were examined by bronchoalveolar lavage and histopathology. Inhaled Ceria is deposited in the lung and cleared with a half-time of 40 days; at aerosol concentrations higher than 0.5 mg/m 3 , this clearance was impaired resulting in a half-time above 200 days (25 mg/m 3 ). After 5 days, Ceria (>0.5 mg/m 3 ) induced an early inflammatory reaction by increases of neutrophils in the lung which decreased with time, with sustained exposure, and also after the exposure was terminated (during the post-exposure period). The neutrophil number observed in bronchoalveolar lavage fluid (BALF) was decreasing and supplemented by mononuclear cells, especially macrophages which were visible in histopathology but not in BALF. Further progression to granulomatous inflammation was observed 4 weeks post-exposure. The surface area of the particles provided a dose metrics with the best correlation of the two Ceria’s inflammatory responses; hence, the inflammation appears to be directed by the particle surface rather than mass or volume in the lung. Observing the time course of lung burden and inflammation, it appears that the dose rate of particle deposition drove an initial inflammatory reaction by neutrophils. The later phase (after 4 weeks) was dominated by mononuclear cells, especially macrophages. The progression toward the subsequent granulomatous reaction was driven by the duration and amount of the particles in the lung. The further progression of the biological response will be determined in the ongoing long-term study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00204-014-1349-9

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Study design of short-term studies with 5 days and 4 weeks of exposure
Fig. 1 Study design of short-term studies with 5 days and 4 weeks of exposureCC BY · PubMed Central
Fig. 2 Structure of Ceria. Electron microscopy images of a representative ensemble of particles of Ceria NM-211 (a) and NM-212 (b) (see Table 1 for size characterization by complementary methods)
Fig. 2 Structure of Ceria. Electron microscopy images of a representative ensemble of particles of Ceria NM-211 (a) and NM-212 (b) (see Table 1 for size characterization by complementary methods)CC BY · PubMed Central
Fig. 3 Persistence of Ceria NM-211 (a), NM-212 (b), and Titania NM-105 (c) as benchmark. Transmission electron microscopy (TEM) and selected area diffraction (SAD) after 28-day incubation in phagolysosomal simulant fluid (PSF) [see Table 1 for dissolution detected by ions in the supernatant (ICP-MS)]. The large almost spherical structures are no contaminations, but are confirmed as Ceria in the same crystalline phase
Fig. 3 Persistence of Ceria NM-211 (a), NM-212 (b), and Titania NM-105 (c) as benchmark. Transmission electron microscopy (TEM) and selected area diffraction (SAD) after 28-day incubation in phagolysosomal simulant fluid (PSF) [see Table 1 for dissolution detected by ions in the supernatant (ICP-MS)]. The large almost spherical structures are no contaminations, but are confirmed as Ceria in the same crystalline phaseCC BY · PubMed Central
Fig. 4 Comparison of changes in BALF parameters after 5 days (a, b) and 4 weeks (c, d) of exposure to Ceria NM-211 and NM-212: short-term study with 5 days of exposure: a 3 days after the end of exposure, b 24 days after the end of exposure; short-term study with 4 weeks of exposure, c 1 day after the end of exposure, d 35 days after the end of exposure. Changes are shown as x-fold differences compared to controls using a logarithmic scaling
Fig. 4 Comparison of changes in BALF parameters after 5 days (a, b) and 4 weeks (c, d) of exposure to Ceria NM-211 and NM-212: short-term study with 5 days of exposure: a 3 days after the end of exposure, b 24 days after the end of exposure; short-term study with 4 weeks of exposure, c 1 day after the end of exposure, d 35 days after the end of exposure. Changes are shown as x-fold differences compared to controls using a logarithmic scalingCC BY · PubMed Central
Fig. 5 a Microscopic appearance of lungs (a–d) in the short-term study with 4 weeks of exposure. a Control, lung; b 2 days after the end of exposure to 25 mg/m3 Ceria NM-212: lung, alveolar histiocytosis with particles; c, d 34 days after the end of exposure to 25 mg/m3 Ceria NM-212: lung, granulomatous inflammation. b Microscopic appearance of lungs (e, f) in the short-term study with 4 weeks of exposure; e control, BALT; f 34 days after the end of exposure to 25 mg/m3 Ceria NM-212: BALT macrophage aggregates with particles. c Microscopic appearance of lung-associated lymph nodes (g, h) in the short-term study with 4 weeks of exposure; g control, lymph node; h 34 days after the end of exposure to 25 mg/m3 Ceria NM-212: tracheobronchial lymph node, macrophage aggregation with particles
Fig. 5 a Microscopic appearance of lungs (a–d) in the short-term study with 4 weeks of exposure. a Control, lung; b 2 days after the end of exposure to 25 mg/m3 Ceria NM-212: lung, alveolar histiocytosis with particles; c, d 34 days after the end of exposure to 25 mg/m3 Ceria NM-212: lung, granulomatous inflammation. b Microscopic appearance of lungs (e, f) in the short-term study with 4 weeks of exposure; e control, BALT; f 34 days after the end of exposure to 25 mg/m3 Ceria NM-212: BALT macrophage aggregates with particles. c Microscopic appearance of lung-associated lymph nodes (g, h) in the short-term study with 4 weeks of exposure; g control, lymph node; h 34 days after the end of exposure to 25 mg/m3 Ceria NM-212: tracheobronchial lymph node, macrophage aggregation with particlesCC BY · PubMed Central
Fig. 6 Biokinetics of lung (a–c) and lymph node burdens (c) in the short-term study with 4 weeks of exposure. Lung burden after exposure to 0.5 mg/m3 (a), 5 mg/m3 (b), and 25 mg/m3 (c) Ceria NM-212 and burden of lung-associated lymph nodes after exposure to 25 mg/m3 Ceria NM-212 (c, green) after 4 weeks of exposure and during 129 days post-exposure
Fig. 6 Biokinetics of lung (a–c) and lymph node burdens (c) in the short-term study with 4 weeks of exposure. Lung burden after exposure to 0.5 mg/m3 (a), 5 mg/m3 (b), and 25 mg/m3 (c) Ceria NM-212 and burden of lung-associated lymph nodes after exposure to 25 mg/m3 Ceria NM-212 (c, green) after 4 weeks of exposure and during 129 days post-exposureCC BY · PubMed Central
Fig. 7 Dose–response curves using different dose metrics after 5 days of exposure to 0.5 and 25 mg/m3 Ceria NM-211 and 0.5, 5, and 25 mg/m3 Ceria NM-212; a mass, b surface, c volume
Fig. 7 Dose–response curves using different dose metrics after 5 days of exposure to 0.5 and 25 mg/m3 Ceria NM-211 and 0.5, 5, and 25 mg/m3 Ceria NM-212; a mass, b surface, c volumeCC BY · PubMed Central
Fig. 8 Inflammatory potency of the short-term studies with 5 days and 4 weeks of exposure over post-exposure period: absolute neutrophil counts in BALF in the short-term studies: 3 and 24 days after end of exposure to 25 mg/m3 Ceria NM-211 (orange 5-day exposure) and NM-212 (light blue 5-day exposure) or one and 35 days after the end of exposure to 25 mg/m3 NM-212 (dark blue 4-week exposure)
Fig. 8 Inflammatory potency of the short-term studies with 5 days and 4 weeks of exposure over post-exposure period: absolute neutrophil counts in BALF in the short-term studies: 3 and 24 days after end of exposure to 25 mg/m3 Ceria NM-211 (orange 5-day exposure) and NM-212 (light blue 5-day exposure) or one and 35 days after the end of exposure to 25 mg/m3 NM-212 (dark blue 4-week exposure)CC BY · PubMed Central
Fig. 9 Neutrophil counts in BALF correlated with deposited particle per surface lung after 5-day and 4-week exposure using the aerosol concentrations of 0.5, 5, and 25 mg/m3 CeO2 NM-212 for each point
Fig. 9 Neutrophil counts in BALF correlated with deposited particle per surface lung after 5-day and 4-week exposure using the aerosol concentrations of 0.5, 5, and 25 mg/m3 CeO2 NM-212 for each pointCC BY · PubMed Central
Fig. 10 Summary of results after 5 days and 4 weeks of exposure to Ceria
Fig. 10 Summary of results after 5 days and 4 weeks of exposure to CeriaCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

6 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 72 references

Research works printed but not linked: 5

  1. European Commission (2014) Science and policy report by the joint research centre, the European Commission, JRC89825, EUR 26649 EN. Publications office of the European union, Luxembourg. doi:10.2788/80203 · doi:10.2788/80203
  2. Federal Ministry for the Environment (2012) NCBaNS Langzeitforschungsprojekt zur Sicherheit von Nanomaterialien gestartet, press release no. 066/12. Federal Ministry for the Environment, Berlin. http://www.bmub.bund.de/presse/pressemitteilungen/pm/artikel/langzeitforschungsprojekt-zur-sicherheit-von-nanomaterialien-gestartet-1/
  3. PROSPEcT: Ecotoxicology Test Protocols for Representative Nanomaterials in Support of the OECDSponsorship Programme (2010) Toxicological review of nano cerium oxide. http://www.nanotechia.org/sites/default/files/files/PROSPECT_Nano-CeO2_Literature_Review.pdf
  4. Teunenbroek T, Dijkzeul A, Hoehener K (2013) NANoREG-A common European approach to the regulatory testing of nanomaterials, Press release, NANoREG. http://www.nanoreg.eu/images/NANOREG_PressRelease_final.pdf
  5. Wohlleben W, Ma-Hock L, Boyko V, Cox G, Egenolf H, Freiberger H, Hinrichsen B, Hirth S, Landsiedel R (2013) Nanospecific Guidance IN REACH: a comparative physical–chemical characterization of 15 materials with methodical correlations. J Ceram Sci Technol 4:93–104

Cited by

Items 101–124 of 124

Metadata

Authors
Keller, J., Wohlleben, W., Ma-Hock, L., Strauss, V., Gröters, S., Küttler, K., Wiench, K., Herden, C., Oberdörster, G., van Ravenzwaay, B., & Landsiedel, R.
Affiliations
  • BASF (Germany) (DE)
  • Justus-Liebig-Universität Gießen (DE)
  • University of Rochester Medicine (US)
Corresponding author
Landsiedel, Robert
Venue
Archives of Toxicology
Published
2014-10-02
Volume
88
Issue
11
Pages
2033-2059
ISSN
  • 0340-5761 (ISSN-L)
  • 1432-0738
OpenAlex
W2027912899
Cited by
115
References
73
Citations by year
2026: 5 · 2025: 5 · 2024: 13 · 2023: 4 · 2022: 8 · 2021: 13 · 2020: 12 · 2019: 12 · 2018: 10 · 2017: 17 · 2016: 10 · 2015: 5 · 2014: 1
FWCI
4.99
Type
journal article
Language
en
Open access
Licence
Locations
  • Archives of Toxicology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
European Commission (310451)
Topics
  • Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Keywords
cerium oxide nanoparticles, inhalation toxicity, lung retention, lung burden, granulomatous inflammation, neutrophil recruitment, macrophages, aerosol deposition, bronchoalveolar lavage
MeSH terms
Administration, Inhalation, Aerosols, Animals, Bronchoalveolar Lavage Fluid, Cerium, Dose-Response Relationship, Drug, Female, Granuloma, Inflammation, Lung, Macrophages, Neutrophils, Time Factors, Rats, Wistar, Inhalation Exposure, Nanostructures, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.